The study of BSD2000 deep regional hyperthermia combined with transcatheter arteria chemoembolization in treatment of advanced hepatocellular carcinoma
Ren Da-cheng
Abstract
Ren Da-cheng
Abstract
Objective To study effects of BSD2000 deep regional hyperthermia combined with transcatheter arteria chemoembolization(TACE) in treatment of advanced hepatocellular carcinoma.Methods 36 patients with advanced hepatocellular caicinoma were randomly divided into two groups(each group with 18 cases).The observed group was treated with BSD2000 deep regional hyperthermia combined with TACE.The contrast group with TACE single.Results The total effective rates with the observed group and contrast group were 72.2%(13/18)and 38.9%(7/18),respectively(P0.05).The clinical benefit response rates were 83.3 %(15/18)and 38.9%(7/18),respectively(P0.05).There was no significant difference in the survival rates for 0.5,1,1.5 years(P0.5),but difference was statistically significant for 2 years(P0.05) between the two groups.There was no significant difference in side-effects between the two groups.Conclusion BSD2000 deep regional hyperthermia combined with transcathe ter arteria chemoembolization is more effective than single TACE in treatment of advanced hepatocellular carcinoma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study effects of BSD2000 deep regional hyperthermia combined with transcatheter arteria chemoembolization(TACE) in treatment of advanced hepatocellular carcinoma.Methods 36 patients with advanced hepatocellular caicinoma were randomly divided into two groups(each group with 18 cases).The observed group was treated with BSD2000 deep regional hyperthermia combined with TACE.The contrast group with TACE single.Results The total effective rates with the observed group and contrast group were 72.2%(13/18)and 38.9%(7/18),respectively(P0.05).The clinical benefit response rates were 83.3 %(15/18)and 38.9%(7/18),respectively(P0.05).There was no significant difference in the survival rates for 0.5,1,1.5 years(P0.5),but difference was statistically significant for 2 years(P0.05) between the two groups.There was no significant difference in side-effects between the two groups.Conclusion BSD2000 deep regional hyperthermia combined with transcathe ter arteria chemoembolization is more effective than single TACE in treatment of advanced hepatocellular carcinoma.
Key concepts: Medicine, Hepatocellular carcinoma, Transcatheter arterial chemoembolization, Hyperthermia, Significant difference, Internal medicine, Radiology, Gastroenterology